Neuromuscular diseases and social distance resulting from the COVID-19 pandemic
Open Access
- 29 September 2022
- journal article
- research article
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 80 (07) , 712-717
Abstract
Background Coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2), generically called COVID-2019, classified as a pandemic by the World Health Organization, has made health practices around the world face unique challenges. Since then, physical distancing and measures such as confinement have been adopted by different governments to control human-to-human transmission. This distance affected the treatment of individuals with progressive diseases such as neuromuscular diseases (NMDs). Objective To identify how patients with NMDs performed the therapeutic routine during social distancing and confinement resulting from the COVID-19 pandemic. Methods Application of a questionnaire prepared in the Google forms application, whose link for access and participation was sent by email or WhatssApp for family members and/or individuals with DNMs to respond. The questionnaire consisted of multiple-choice questions, divided into the following sections: personal data, treatments performed before and during the pandemic, activities performed during confinement, and characterization of motor function in activities of daily living comprising the period between September and October 2020. Results We observed a significant reduction in medical appointments for patients with NMDs. On the other hand, the results showed that most patients underwent motor and/or respiratory physiotherapy in person or by telemonitoring. The study participants reported spending more time playing indoors, and all pointed out motor changes during social distancing. Conclusion There were changes in the therapeutic routine of patients with NMDs during the period of social distancing due to COVID-19.Keywords
This publication has 13 references indexed in Scilit:
- Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanismsBrain, Behavior, and Immunity, 2020
- COVID-19 and neuromuscular disordersNeurology, 2020
- Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases NetworkRevue Neurologique, 2020
- On being a neurologist in Italy at the time of the COVID-19 outbreakNeurology, 2020
- The COVID‐19 epidemicTropical Medicine & International Health, 2020
- Exercise therapy in muscle diseases: open issues and future perspectives2019
- Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart AssociationCirculation, 2017
- Neuromuscular DiseaseJournal of Pediatric Rehabilitation Medicine, 2016
- Exercise in Neuromuscular DiseaseSeminars in Neurology, 2014
- Overview of paediatric neuromuscular disorders and related pulmonary issues: diagnostic and therapeutic considerationsPaediatric Respiratory Reviews, 2010